Report Categories
View AllRecent Articles
View All
OPRT Oportun beats Q4 2025 EPS estimates by 103 percent shares gain 191 percent in todays session
BEN Warrant BNAIW CEO highlights AI engagement momentum but delays revenue reporting amid business model evolution
Voyager Therapeutics VYGR Stock Support Breakdown Risk Q4 2025 EPS Beats Forecasts
Exelon Corporation EXC Q1 2026 Earnings Preview Modest Revenue Growth Expected Amid Earnings Pressures Upside Surprise Potential Remains Mixed